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The state of Mississippi is undergoing a prescription opioid epidemic that mimics
national trends in which prescribing rates are dropping, yet overdoses involving opioids remain
high. In response to the state’s crisis, the PReventing Opioid Misuse In the SouthEast
(PROMISE) Initiative was created to provide education for preventing the misuse of prescription
opioids. A mail survey and post card intervention were distributed in six Appalachian counties in
the state to gather the self-reported attitudes, norms, and perceived behavioral control of
residents as it related to using a prescription drug take-box. Descriptive and multivariable
analyses indicate the intervention did not increase intention to use prescription drug take-back
boxes as a method of disposal. Lack of awareness and inconvenience remain common themes
among individuals who chose not to use take-back boxes. Thus, researchers recommend future
interventions incentivize prescription disposal.
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CHAPTER I
INTRODUCTION
The United States’ Opioid Epidemic
Opioids are defined as all natural, synthetic, or semi-synthetic chemicals that interact
with opioid receptors in the body and brain to reduce the intensity of pain signals and feelings of
pain (Centers for Disease Control and Prevention [CDC], 2018). Prescription opioids such as
OxyContin® and Vicodin® are prescribed by health care providers for acute and chronic pain
relief, active-phase cancer treatment, palliative care, and end of life care (American Psychiatric
Association, 2018). When they are not overprescribed and used as directed, prescription opioids
can be helpful for patients in pain. But side effects such as pain reduction and euphoria are
highlighted as potential factors for misuse of these medications (National Institute on Drug
Abuse [NIDA], 2020). In the past, addictive qualities of prescription opioids were not always
widely noted by physicians and researchers.
In 1980, the New England Journal of Medicine (NEJM) published a letter to the editor
entitled, “Addiction Rare in Patients Treated with Narcotics” (Porter & Jick, 1980). The authors
affirmed although the use of narcotic drugs in hospitals was common, there was a rare chance of
developing an addiction to the drugs among patients with no history of addiction. Recently,
authors, Leung et al., conducted a bibliometric analysis on the letter in which they identified 608
citations of the publication between the original publication date and March 2017. There was a
notable increase in citations within the medical literature that occurred after the introduction of
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OxyContin® in the year 1995. Beginning in the 1990s, pharmaceutical companies began
marketing campaigns to convince doctors to prescribe opioids to their chronic pain patients
(NIDA, 2020). These campaigns, often misrepresented conclusions from the NEJM letter, misled
doctors about the addictive qualities of these opioids and advised them that these medications
were optimal treatment for pain management (Leung, Macdonald, Dhalla, & Juurlink, 2017).
There was also a movement within the industry, to adopt pain, or the presence of pain as a fifth
vital sign for patients (American Pain Society, 1999). These persuasive campaigns propelled the
idea, to ignore pain was to ignore your patients. The persistence of the campaign messages
convinced some doctors to prescribe these medications to their patients under the assumption
that they were doing the best thing for their patients (Morone & Weiner, 2013). What was to
come from the increase in prescribing opioids was unknown for millions of prescribers, their
patients, and their families.
Patients’ responses to the increase of prescribing rates of prescription opioids in the
1990s gave birth to what is now credited as the “first wave” of the opioid epidemic in the U.S.
(CDC, 2019). An increase in illicit opiates such as heroin followed (Rudd et al. 2014) During
2013, significant increases in overdose deaths involving synthetic opioids, primarily
manufactured fentanyl, marked the beginning of the “third (and current) wave” of the U.S.
opioid epidemic. As of 2018, reports indicated that nearly 128 Americans were dying from an
opioid overdose daily (CDC, 2018).
The Opioid Epidemic’s Impact on Rural America
The CDC analyzed patients’ opioid prescription data from Athenahealth, which revealed
rural areas had higher percentages of opioid prescriptions and opioid-related deaths than urban
areas (American Academy of Family Physicians, 2019). Prominent employment opportunities in
2

rural communities are often in the manufacturing and service industries, which are associated
with an increased risk of occupational injuries and chronic pain, often alleviated with
prescription opioids (Dasgupta, Beletsky, & Ciccarone, 2018). Furthermore, 74% of farmers and
farm workers were reporting being directly impacted by opioid abuse either reporting personally
having taken an opioid, dealt with their own addiction, or had a family member or acquaintance
who was addicted to opioids (American Farm Bureau Federation, 2017). In a poll launched by
the American Farm Bureau Federation, three out of four farmers stated it would be easy for
someone in their community to access illegal opioids. Contrarily, one in three farmers stated it
would be easy to access proper treatment for substance use issues.
Coupled with the ease of access issues, there are emerging diseases of despair, a concept
in public health that suggests that conditions such as suicide, drug overdose (specifically from
opiates), and alcohol liver disease are the common causes of midlife mortality and are present in
geographic regions that have been hit the hardest by economic decline such as parts of
Appalachia (Shanahan et al., 2019). Appalachia is a vast, 205,000-square mile region of the
United States spanning across the Appalachian Mountains, which range from southern New
York to northern Mississippi (Meit, Heffernan, Tanenbaum, & Hoffman, 2017). These diseases
of despair stem from causes such as lack of economic opportunities (i.e., coal mines closing),
unfavorable working conditions, or depressed communities (Dasgupta, Beletsky, & Ciccarone,
2018).
Prescription drug dispensing rates were accredited with marking the beginning of today’s
opioid epidemic. Although there have been changes with increased knowledge about the effects
of opioids and prescribing rates; dispensing rates remain an issue in different regions of the
country. During 2019, there were more than 2.5 million opioid prescriptions, and over 130.3
3

million opioid dosage units (e.g., pills) dispensed in the state of Mississippi (Mississippi Opioid
and Heroin Data Collaborative, 2020). More alarming, roughly 70% of people who have abused
prescription drugs across the nation have said they received the drugs from a family member or
friend (U.S. Department of Justice Drug Enforcement Administration, 2019). Reports have
suggested that this ease of access to prescription drugs, specifically opioids, is a large contributor
to the epidemic (McCabe, Boyd, Ranford, & Teter, 2009; Office of National Drug Control Policy
[ONDCP], 2014, Johnston, O’Malley, Miech, Bachman, & Schulenberg, 2015).
As more information is revealed about the role of pharmaceutical companies in
manufacturing the current opioid epidemic, many U.S. states and individual families have
pursued legal action against companies such as Purdue Pharma (creators of OxyContin®) and
Johnson and Johnson. Proceedings from the lawsuits have been highly publicized in the media
with many of them concluding in multibillion-dollar settlements and pharmaceutical companies
declaring bankruptcy and pleading to criminal charges (Soelberg et al., 2017).
Mississippi’s Opioid Epidemic and Related Challenges
The opioid epidemic has left no region of the U.S. unharmed. In particular, the state of
Mississippi, which is primarily rural is experiencing an epidemic that is following national trends
(American Medical Association, 2017). Despite the decrease in prescribing rates of opioids and
increase in state efforts to address the epidemic, opioid-related deaths remain high (American
Medical Association, 2017).
According to data from the Mississippi Bureau of Narcotics (MBN), 64.5% of the
suspected overdose deaths throughout the state are opioid-related, with 45.7% of opioid-related
deaths being linked to prescription opioids (Mississippi Department of Health, 2019). Quarterly
data reports over 577,000 opioid prescriptions and more than 30.4 million opioid dosage units
4

(e.g. pills) were dispensed in the state of Mississippi (Mississippi Opioid and Heroin Data
Collaborative, 2020). The reported prescriptions have decreased by a total of 68,695 and dosage
units have decreased by over 2.5 million since last year’s reports were published.
In response to the state’s opioid crisis, the “PReventing Opioid Misuse In the SouthEast”
(PROMISE) Initiative was launched to provide a multi-phased, education program to a
prescription opioid misuse throughout rural Mississippi (Robertson et al., 2019). Prior to the
launch of the program, members of the PROMISE team conducted community engagement
forums to gain deeper understanding and perceptions of the opioid crisis from individuals within
communities. Forum proceedings unveiled an array of opinions and perceptions regarding the
opioid crisis, the landscape of their communities, and prescription drug take-back boxes.
Prescription drug take-back boxes are monitored boxes that provide a safe and environmentally
conscious place for individuals to properly dispose of unused prescription medications (Food and
Drug Administration, 2020). Prescription drug take-back boxes are commonly located inside of
chain pharmacies (i.e., CVS or Walgreens) or law enforcement stations.
First, there were participants who had not seen or heard of a prescription take-back box.
Then, there were others in the focus groups who expressed their reservations for the prescription
take-back boxes. For instance, some individuals expressed reluctance about the placement of
take-back boxes being placed at the local sheriff’s office and using them to dispose of their
medications. Others felt concern about the safety of the boxes from community members, one
participant stated, someone could steal the take-back box with a chain. The alarming amount of
prescription pills dispensed in the state of Mississippi and attitudes about using prescription takeback boxes among citizens informed the decision of creating an intervention to gather more
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information about community perceptions and likelihood of using prescription drug take-back
boxes (Robertson et al., 2021).
In attempts to address the excess of unused pills lingering throughout communities
nationwide, several community-based public health interventions have been launched to market
the importance of prescription drug disposal campaigns. Large agencies such as the Drug
Enforcement Agency (DEA), have launched nationwide drug take-back events. National drug
take-back days are often scheduled annually or biannually. To provide a more accessible option
for individuals, there have been more installations of prescription drug take-back boxes in
communities in which people can dispose of their medications throughout the year (Gray,
Hagemeier, Brooks, & Alamian, 2015).
Currently the statewide campaign for the state, Stand Up Mississippi, does not include
primary prevention information or resources on opioid misuse. Rather than duplicate an existing
campaign, the PROMISE Initiative sought to collaborate with the Stand Up Mississippi team to
provide the preventive information to include on the official website and publication. Due to the
limited research available of preventive prescription opioid campaigns in the state, PROMISE
looked to published literature to help inform a multi-phased approach with social marketing
elements suitable for rural communities.
Research Opportunities
Although there has been an increase in educational campaigns designed to address the
opioid epidemic, specifically the excess of prescription opioids throughout communities, the
epidemic continues to persist, and researchers are seeking ways to tailor educational initiatives.
During 2019, there were more than 2.5 million opioid prescriptions dispensed, and over 130.3
million opioid dosage units (e.g., pills) dispensed in the state of Mississippi (Mississippi Opioid
6

and Heroin Data Collaborative, 2020). Research suggests excess amounts of expired, unused, or
unwanted opioids throughout communities pose a threat of diversion and potential misuse of the
medicines (Helme et al., 2020). Thus, proper disposal of these medicines would be a
recommended behavior for preventing prescription opioid misuse. While behavioral
interventions regarding disposal of prescription opioids have been launched before, there are no
known studies about mail interventions seeking to positively influence perceptions and behaviors
of prescription opioid disposal in the state of Mississippi. The PROMISE Initiative mailer
surveys sought to determine the community members’ perceptions of prescription drug take-back
use among rural Mississippians as a preventive behavior.
Overall, the findings from previous studies uncovered attitudes and behaviors consistent
with choosing not to use prescription drug take-back boxes due to the perception of
inconvenience or holding on to them for future use. The PROMISE Initiative composed a
prescription drug take-back box mailer intervention to measure take-back box use throughout the
state and the underlying factors contributing to the decision to do so (or forego). The intended
audience for the mail out intervention was rural Mississippians. According to the Federal
Communications Commission, Mississippi is highlighted as one of 50 U.S. states ranking low in
terms of internet access for residents. Besides limited access, actual speed of internet service is
an additional concern in the state (Woodruff, 2020). Due to these factors, PROMISE team
members proposed a mail intervention, in which postcard-sized surveys will be mailed to
residents in the control and intervention counties, followed by an intervention promoting a
specific preventive behavior (i.e., disposal of prescription opioids).
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Fishbein and Azjen’s Reasoned Action Approach
The PROMISE Initiative’s mail out survey intervention was based on Fishbein and Azjen’s
Reasoned Action Approach (2010), an extension of Theory of Planned Behavior and Theory of
Reasoned Action (Figure 1). The basis of the Reasoned Action Approach states, intention is the
single best indicator of whether someone will engage in a specific behavior. According to the
authors, intentions are informed by three types of considerations: attitudes, perceived norms, and
perceived behavior control (Azjen & Albarracín, 2007). General beliefs about a particular course
of action ultimately informs an individual’s attitude regarding the behavior. Attitudes are an
individuals’ personal evaluation of the behavior whether favorable or unfavorable (National
Cancer Institute, 2005). One aspect of attitude includes instrumental attitude, which is an
evaluation of positive or negative attributes (i.e., very good or very bad). The second aspect is
experiential attitude, which is an evaluation of the whether there was a positive or negative
experience (i.e., convenient, or inconvenient). Perceived norms relate to a person’s perceived
social pressure on whether (or not) they will engage in a particular behavior and are comprised of
two forms: descriptive and injunctive. Descriptive norms relate to the perception of how other
people behave. Whereas injunctive norms are the perceptions of what should be or ought to be
the norm (Fishbein and Azjen, 2010). Perceived behavioral control are composed of two separate
aspects – capacity and autonomy. Capacity is the individual’s belief in their ability to perform a
specific behavior and autonomy is the individual’s belief that the decision to perform a specific
behavior is up to them (Yzer, 2017). The pre- and post- mailer surveys will assist in measuring
these constructs among respondents.
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Figure 1.1

The Reasoned Action Approach Model (Fishbein & Azjen, 2010)
Research Question

Because rural communities in the U.S., such as the state of Mississippi, are significantly
impacted by the opioid crisis; the PROMISE Initiative was funded to initiate prescription opioid
misuse prevention efforts in three, rural Mississippi counties – Lee, Itawamba, and Tishomingo.
Formative research suggests that proper disposal of prescription opioids is a behavior that
prevent prescription opioid misuse. Considering the impact of the opioid epidemic and sparse
internet access in rural communities, we plan to distribute the mailers to answer the following
research question: What are rural Mississippians’ self-reported attitudes, descriptive norms,
injunctive norms, and perceived behavioral control as they relate to using a prescription drug
take-back box?
Hypotheses
Due to the responses from the community engagement forums, we hypothesize the
PROMISE Mailed Intervention Postcard illustrating take-back box use and detailing the nearest
location, will increase the number of individuals who use take-back boxes at the time of
9

receiving the post-survey (behavior). In addition to an increase in behavior, we hypothesize the
intervention will contribute to an increase confidence in using take-back boxes and intent to use
take-back boxes as a method of disposal in the future.
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CHAPTER II
LITERATURE REVIEW
Opioid misuse has become a national problem. While many approaches to curbing this
epidemic have been undertaken, there are considerable number of projects focused on
encouraging the proper disposal of empty, expired, or unused prescription opioids using social
marketing strategies and health behavior change theories.
The American Chest Challenge
The American Medicine Chest Challenge (AMCC) was a community-based public health
program designed to increase awareness about prescription drug abuse and encouraged proper
disposal of expired, unwanted, or unused (EUU) prescription medications (Yanovitzky, 2017).
The campaign recommends adults and families participate in the following preventive behaviors,
known as the AMCC’s Five Step Challenge: take inventory of medicine stored in the home, lock
medicine in a cabinet, safely dispose of EUU medicines, take medicines as prescribed, and talk
to children about the dangers of prescription drugs. The campaign employed a community-based
prevention marketing strategy, and focused on building a coalition of law enforcement,
government, media, and other stakeholders. The researchers sought to estimate the reach and
influence of the campaign throughout the state of New Jersey by collecting survey data from a
representative sample of residents. For three years, telephone interviews were conducted with
members of the sample.
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Respondents who reported being exposed to the AMCC campaign were asked to assess
the degree to which they learned about safe disposal of empty, unused, and unwanted
medications in their home and whether they were influenced to take action after exposure to the
campaign, on a 5-point scale ranging from “none” to “a great deal”. All respondents were asked
five, Likert-questions that measured perceived severity (“using or sharing prescription medicine
that was prescribed to someone else is dangerous) and perceived susceptibility (“I am concerned
about other members of my household using and sharing prescription and over-the-counter
medicine that was not prescribed to them”). Nearly half of respondents exposed to the campaign
reported they learned some or a lot about safe disposal of empty, unused, or unwanted medicine
from the information provided in the campaign. Only one third of respondents reported the
information influenced them to safely dispose of the medicine.
Across the three-year campaign period, between 36% and 42% of all respondents
reported taking inventory of the EUU medicine in their home, and less than 20% of respondents
kept their medicine locked in a cabinet. Forty percent of respondents self-reported not taking
any actions to dispose of EUU medicines, and about half of these respondents stated they did not
have EUU in the home. Additional medicine disposal methods included: placing medicine in the
trash (24-30%), flushing medicine down the drain (13-19%), and using drug collection sites (1016%). Therefore, roughly 80% of individuals (each year) who possessed EUU medicine
employed at least one of the actions suggested by the American Chest Challenge’s Take Five
Challenge.
Yanovitzky stated, community participation in prescription medication disposal may be
greater when there are strong social norms and community organizing to support the behavior.
On the other hand, reports of low disposal are contributed to the belief that EUU medicine
12

should remain stored in the home for cases of convenience, such as a medical emergency,
reoccurrence of the condition that warranted the prescription, and as an economic incentive of
maintaining expensive medication. Easy access to medications is an important contributor to the
epidemic of prescription drug misuse. Promoting safe and environmentally responsible disposal
methods of medicine continues to be an important component of the national strategy for
decreasing the availability of prescription medications.
After analysis, Yanovitzky identified a modest positive correlation between exposure to the
campaign and general exposure to information about prescription drug abuse in the media across
the three-year cross-sectional samples. Results from the AMCC study confirmed that drug takeback events are potentially effective for decreasing the availability of prescription drugs in
communities. Thus, programs such as these continue to be promoted as the most effective option
to the general public.
Encouraging Disposal of Unused Opioid Analgesics in Appalachia
Appalachia has been disproportionately impacted by the opioid epidemic (Helme et al.,
2020). Although the overall number of opioids being prescribed has decreased, large quantities
of these prescriptions remain throughout communities due to non-disposal of unused
prescriptions. Research findings have indicated that there are large quantities of empty, unused,
or unwanted medicines within homes in the U.S. Leftover prescription opioids within the home
can increase of individuals misusing these prescription and prescriptions being intercepted by
someone else in the home. National strategies to address opioid misuse have included campaigns
to promote proper disposal of these unused or unwanted medicines whether it is through takeback events or permanent prescription take-back boxes. Despite the increase in these prescription
drug-take back events and take-back boxes, low utilization rates persist for these disposal
13

options. Helme and colleagues (2020) assert that a critical step in developing health promotion
campaigns is understanding the awareness and perceptions of the target audience.
Researchers developed thematic and qualitative focus groups to analyze the community
members’ perception of medicine disposal programs to provide researchers with a foundation to
inform the design and implementation of effective, communication campaigns encouraging these
disposal methods. Five Appalachian counties, three in Kentucky and two in North Carolina were
selected as sites for the focus groups based on the following criteria: high rate of prescription
opioid overdose deaths, high rates of controlled medication prescription, and classification as an
Appalachian community by the Appalachian Regional Commission. Inclusion criteria for focus
group participants included being a resident in the local community and being 18 years of age or
older.
Results from the inductive, thematic focus groups were organized using five constructs
from the Health Belief Model (Becker, 1974): perceived susceptibility to the prescription opioid
epidemic, perceived severity of the prescription opioid epidemic, perceived benefits of disposing
unused prescription opioids, barriers to disposing unused prescription opioids, and self-efficacy
(or lack thereof) of using prescription drop-boxes. Drug use as a ‘family tradition’, economic
depression, were the primary themes under the perceived susceptibility construct. Many focus
group participants expressed misuse of prescription opioids was an intergenerational concern in
families, with one participant quoted stated, “It’s a family tradition. It just keeps going. You’ll
see a family that’s on drugs, 99% of the time, them kids will be – unless they wanna fight it”.
The economic depression and lack of employment opportunities was an additional theme
throughout the focus groups, in which participants suggested that community members could be
drawn to the nonmedical opioid use as a form of escape from the reality of their community.
14

Health consequences and having trouble obtaining legitimate access to medication were
primary themes of perceived severity of the prescription opioid epidemic. Fatal overdose and
other adverse health issues of nonmedical use of prescription opioids were a common theme of
severity. Participants also discussed that the “crackdown” response on prescription opioid
prescribing rates has made it difficult for individuals to obtain valid opioid prescriptions.
Perceived benefits of disposing unused prescription opioids included protection against
robbery and burglary, prevention against misuse, prevention of accidental ingestion by
household members, and no longer wanting or needing medications. By properly disposing of
unused or unwanted prescriptions participants believe they were protecting themselves against
potential robberies for their medications, potential diversions and risks of misuse by themselves
or others, and potential accidental ingestion of the opioids by others in the household such as
small children. Finally, participants insisted that simply no longer needing or wanting the
medicine as a benefit for proper disposal because they would be able to get rid of them once their
condition had improved, and they were no longer in possession.
Barriers to disposing unused and unwanted prescription opioids are keeping the
medicines “just in case” and mistrust of authority. Like previous studies seeking to identify
perceptions and motivation of proper prescription opioid disposal, many community members
stated choosing not to dispose of the medicines as a matter of convenience in both time and
costs. By keeping unused medicine in their possession, they would not have to return to the
doctor in the case of a condition reoccurring and would not have to repay for the medicines,
which are typically expensive. In addition to convenience, a common barrier to disposal is
mistrust for placement of take-back boxes at law enforcement agencies. Participants in these
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particular focus groups believed law enforcement agencies to be corrupt, citing past cases of
corrupt officers and discrimination against individuals suspected of opioid use or overdose.
The final construct of the Health Belief Model, self-efficacy, was difficult to assess
because participants were unfamiliar with prescription take-back boxes in their communities. In
addition to participants being unaware of the take-back box locations, when they became aware
of the boxes near them, they expressed the need to obtain transportation to these locations. Thus,
choosing to dispose of prescription medicines at take-back boxes would be an inconvenience, as
they could choose to flush them, dispose of them in the trash, or return them to their healthcare
provider. Their findings suggest that messaging campaigns that target families, highlight
prevention of theft and misuse, and raise awareness of disposal programs may be effective in
increasing rates of disposal. Furthermore, barriers identified should be addressed in systemic
approaches. Lastly, in order to effectively encourage community members to securely and
properly dispose of their unused opioids, it is imperative to understand how non-medical use of
opioids affects and is perceived by individuals, families, and communities of a region are
impacted by the opioid crisis.
Empowering Post-surgical Patients to Improve Opioid Disposal: A Before and After
Quality Improvement Study.
The opioid epidemic is a multifactorial issue; however, over prescribing has been a larger
factor for excess opioids within communities (Hasak et al., 2017). Hasak and colleagues (2017)
are a group of clinical practitioners who sought to determine whether dissemination of an
educational brochure would improve patients’ disposal of unused opioids after surgery. Prior to
launching the intervention, a pilot study was performed to determine whether patients had
unused opioids after their surgery, and whether they have access to knowledge about disposal
16

methods of excess medications. Patients who self-reported using opioids preoperatively were
excluded from participation in the intervention study. The goal of the intervention study was to
determine the effectiveness of the educational brochure on increasing disposal of unused opioids
after surgery. Thirty patients participated in the pilot study and were prescribed an average of 36
opioid pills. At the conclusion of the study, patients had only taken an average of 12 pills,
leaving an average excess of 24 pills. Most patients in the pilot study kept their medications after
surgery and reported they had not received any educational material about disposal of unused
medicines. After the pilot study, there were over 500 unused opioid pills being stored in homes
of the 30 pilot study participants.
The intervention study included patients who were over the age of 18 and underwent
surgery at least two weeks prior to the launch of the intervention and had the ability to interpret
the survey in English. Patients who had their first outpatient clinic visit between February 21 and
March 21, 2017 were enrolled in the control group and would not receive the educational
brochure; those who had their first visit between March 22 and September 15, 2017 were
assigned to the intervention group and received the educational brochure. The educational
brochure was designed based on previously published guidelines and included statistics about the
opioid epidemic, results from the pilot study, instructions for proper disposal of unused opioids,
and website addresses to direct patients to opioid take-back locations. The recommended options
for disposal include returning medicines to the pharmacy, returning them to a police station,
mixing the medicines in an unpalatable substance, and disposing of the mixture in the trash. The
intervention group received the educational brochure prior to the time of their surgery scheduling
and after being discharged from the hospital. Between the control and intervention group, 75
patients reported using their entire prescription, 126 kept their unused opioid pills, and 15
17

patients declined to answer what they did with their excess medicine. Forty-two patients
disposed of their unused opioids and 24 patients did so in a manner recommended by the
educational brochure. After implementation of the education intervention, there was a 10.6%
increase in patients who disposed of their opioids and an 11.6% decrease in keeping unused
medications. Because there were so few patients who disposed of their medications, the findings
from the study were not adequate to declare significant difference in disposal methods among
patients. To better inform the low rates of disposal, the authors included quotes from patients
such as the following: “Saved it for a rainy day for arthritis”, “Keeping it for future surgery”,
“Pharmacy would not take them!”, and “Insurance for if I ever have pain again” (Hasak et al.,
2017). The quotes from the patients in the behavioral intervention further add to the common
theme of choosing not to dispose of medications out of convenience in the case of reoccurrence
of the condition.
Due to the ample amount of research available on the opioid epidemic in rural America
and emphasis on community take-back day interventions, there is a need for literature to address
additional forms of disposal as well as interventions in the state of Mississippi. The PROMISE
Initiative Mail Intervention field experiment will contribute to filling both openings in the
existing literature. Behavioral intention, perceived norms, and perceived behavior control of rural
Mississippians about using prescription drug take-back boxes as a method of disposal for unused
medications will be compiled during implementation. An effective intervention would positively
increase the number of individuals using prescription drug take-back boxes as a method of
disposal of unused medication.

18

CHAPTER III
METHODOLOGY
Design
The PROMISE Initiative was primarily funded in three rural Mississippi counties,
Itawamba, Lee, and Tishomingo. These three counties were the intervention counties. The
control counties, Alcorn, Lowndes, and Prentiss were selected based upon similar demographics
to the intervention counties such as their rural urban continuum (RUC) classification as reported
by the U.S. Department of Agriculture (2020). Itawamba and Alcorn counties were classified as
a “nonmetro-urban population” which constituted a population of 2,500 to 19,999. Lee and
Lowndes were classified as a “nonmetro- urban population” of 20,000 or more. Tishomingo and
Prentiss were slightly different in classification- Tishomingo is classified as “completely rural or
less than 2,500 urban population” and Prentiss is classified as an “urban population of 2,500 to
19,999”. After matching the counties, the PROMISE Team collaborated with the Mississippi
State University Extension Service’s Department of Agricultural Communications for assistance
with recruiting individuals in the intervention and control counties by using their official mailing
list. The blind mailing list included each individual’s county, city, and zip code in which they
lived, as well as their race and gender. There were over 6,000 Mississippians identified in both
the control and intervention counties.
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Mailer Survey
Six questions on the pre- and post- mailer survey were created to address constructs of
Azjen and Fishbein’s Reasoned Action Approach to influence behavioral intention (Azjen &
Albarracín, 2007). Table 1 details the each of the questions, the corresponded reasoned action
approach construct, and the answer choices.
Reasoned Action
Approach Construct
Behavior
Behavioral Intention

PROMISE Mailer Question
Have you used a medicine takeback box in the past month?
How likely are you to use a
medicine take-back box in the
next month?

Attitude

How good or bad would it be for
you to use a medicine take-back
box?

Injunctive norm

Most people who are important
to me approve of my using a
medicine take-back box.

Descriptive norm

Most people like me use a
medicine take-back box.

Perceived Behavioral
Control

I am confident that I could use a
medicine take-back box.

Figure 3.1

PROMISE Mailer
Answer Choices
Yes (1)
No (0)
Very likely (4)
Likely (3)
Neither likely nor unlikely (2)
Unlikely (1)
Very unlikely (0)
Very good (4)
Good (3)
Neither good nor bad (2)
Bad (1)
Very bad (0)
Strongly agree (4)
Agree (3)
Neither agree nor disagree (2)
Disagree (1)
Strongly disagree (0)
Strongly agree (4)
Agree (3)
Neither agree nor disagree (2)
Disagree (1)
Strongly disagree (0)
Strongly agree (4)
Agree (3)
Neither agree nor disagree (2)
Disagree (1)
Strongly disagree (0)

Reasoned Action Approach Constructs and PROMISE Initiative Mailer Surveys
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Demographics
In addition to constructs of the Reasoned Action Approach, the survey contained two
demographic questions to collect gender and age from respondents.
(1) Question 7: What is your gender? A blank space was left for participants to write in their
gender instead of the binary male or female answer choices. Responses were coded as male
and female based on answers; no participants indicated a non-binary gender.
(2) Question 8: “What is your age?” The answer choices and value assigned to the responses
were: 18-29 years old (0), 30-39 years old (1), 40-49 years old (2), 50-59 years old (3), and
60 years old or over (4).
The mail survey did not include a question to self-report race. Thus, the race information
provided by the Agricultural Communications mailing list was used instead.

Figure 3.2

PROMISE Initiative Pre- and Post- Mailer Survey
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Intervention
The PROMISE Initiative Mail Intervention was a dual-sided post card mailed to
participants in the intervention counties and was intentionally designed to impact Reasoned
Action Approach predictors of behavioral intention (Figure 3). The front on the postcard displays
a photo of someone using a prescription take-back box. The decision to include a photo of
someone modeling this behavior was included in an effort to shift the descriptive norms. The
three-step instructions followed by the mention of ease of the process to increase perceived
behavioral control among recipients. An additional phrase included on the postcard states,
“Getting rid of prescription opioids (painkillers) and other medicines you no longer need…” was
included to create a positive attitude around choosing the disposal method.

Figure 3.3

PROMISE Initiative’s Prescription Drug Take-Back Box Mail Intervention (Front)
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Figure 3.4

PROMISE Initiative’s Prescription Drug Take-Back Box Mail Intervention (Back)

Implementation
During Fall 2019, individuals received a packet containing a letter with a description of
this study and a pre-stamped, pre-test survey to be returned to researchers. After completing the
pre-test, researchers implemented an intervention in three of the six counties involved in the
study. The intervention consisted of a mail out flyer displaying an image to inform readers about
prescription drug take-back boxes and how to dispose of unused prescription medications.
Following the launch of the one-time intervention, participants were reassessed through a mail
out packet that contained a pre-stamped, posttest survey to mail back to researchers. The study
consisted of three components: pretest, intervention, and posttest. The identity of the participants
was kept anonymous, and researchers could only view a four-digit ID code for pre-surveys and
“POST- “followed by the four-digit ID code for post surveys. The study was reviewed and
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approved by Mississippi State University’s Institutional Review Board. Pre- and post- test
surveys and intervention post cards were disseminated for three months.
Data Analysis
Pre- and post- mailers were matched using the ID Codes assigned with each mailer.
Using IBM SPSS Statistics (Version 26) software, pre- and post- test analyses were conducted to
assess for changes in behavior, intention, attitude, injunctive norms, descriptive norms, and
perceived behavioral control before and after receiving the intervention for pre- and postmatched surveys only. For participants in the control group, the analysis was conducted to
observe any changes between the pre- and post- tests submitted. Multivariable analyses were
conducted to assess for statistical relationships between dependent and independent variables.
Mann-Whitney U Tests were conducted to examine whether there were differences between both
the intervention and control groups for the following dependent variables: behavioral intention,
attitude, injunctive norms, descriptive norms, and perceived behavioral control. In order to
conduct the Mann-Whitney U tests, change scores were calculated by subtracting dependent
variable pre-test values from the post-test values (Gliner, Morgan, & Harmon, 2003).

24

CHAPTER IV
RESULTS
Descriptive Statistics
The team received a total of 760 responses. Of the total responses 359 were pre-surveys
and 401 were post-surveys; 137 were matched surveys. The sample was primarily comprised of
non-Hispanic Whites and individuals who were 60 years old or over. There were slight
differences of gender distribution throughout control and intervention counties. Results for preand post- matches only are shown in Tables 1 and 1b.
Table 4.1

Descriptive Statistics of MIS Participants by Control and Intervention Groups:
Matched Pre + Post Data
Control
(n=66)

Gender
Female
Male
Unreported
Race
Black
White
Other
Age
18-29
30-39
40-49
50-59
60+

Intervention
(n=71)

30
34
2

36
31
4

1
53
n/a

3
62
2

1
n/a
2
10
53

1
2
6
5
56
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Table 4.2

Descriptive Statistics of Matched MIS Participants Responses to RAA Questions
Control (n=66)
Pre n (%)

Behavior: Have you used
a medicine take-back box
in the past month?
Yes
No
Behavioral Intention:
How likely are you to use
a medicine take-back box
in the next month?
Very Likely
Likely
Neither Likely nor
Unlikely
Unlikely
Very Unlikely
Attitude: How good or
bad would it be for you to
use a medicine take-back
box?
Very Good
Good
Neither Good Nor Bad
Bad
Very Bad

Post n (%)

Intervention (n=71)
Pre n (%)

Post n (%)

3 (4.5)
63 (95.5)

4 (6.1)
62 (93.9)

1 (1.4)
69 (97.2)

n/a
71 (100.0)

4 (6.1)
5 (7.6)

5 (7.6)
3 (4.5)

3 (4.2)
2 (2.8)

2 (2.8)
6 (8.5)

10 (15.2)
20 (30.3)
27 (40.9)

11 (16.7)
22 (33.3)
25 (37.9)

9 (12.7)
20 (28.2)
37 (52.1)

13 (18.3)
21 (29.6)
29 (40.8)

21 (31.8)
16 (24.2)
24 (36.4)
n/a
5 (7.6)

20 (30.3)
15 (22.7)
27 (40.9)
n/a
4 (6.1)

22 (31.0)
19 (26.8)
27 (38.0)
1 (1.4)
2 (2.8)

26 (36.6)
15 (21.1)
27 (38.0)
n/a
2 (2.8)
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Table 4.2 (continued)
Control (n=66)
Pre n (%)
Injunctive Norm: Most people
who are important to me
approve of my using a
medicine take-back box.
Strongly Agree
Agree
Neither Agree Nor Disagree
Disagree

Post n (%)

Intervention (n=71)
Post n
Pre n (%)
(%)

16 (24.2)
17 (25.8)
29 (43.9)
2 (3.0)

17 (25.8)
18 (27.3)
27 (40.9)
n/a

21 (29.6)
9 (12.7)
37 (52.1)
1 (1.4)

22 (31.0)
13 (18.3)
32 (45.1)
3 (4.2)

2 (3.0)

4 (6.1)

3 (4.2)

1 (1.4)

5 (7.6)
2 (3.0)

8 (12.1)
4 (6.1)

3 (4.2)
5 (7.0)

4 (5.6)
6 (8.5)

Neither Agree Nor Disagree 36 (54.5)

34 (51.5)

41 (57.7)

41 (57.7)

Disagree
Strongly Disagree

13 (19.7)
10 (15.2)

10 (15.2)
9 (13.6)

8 (11.3)
12 (16.9)

7 (9.9)
13 (18.3)

22 (33.3)
24 (36.4)

17 (25.8)
29 (43.9)

27 (38.0)
19 (26.8)

26 (36.6)
20 (28.2)

Neither Agree Nor Disagree 10 (15.2)

10 (15.2)

12 (16.9)

13 (18.3)

Disagree

6 (9.1)

2 (3.0)

7 (9.9)

6 (8.5)

Strongly Disagree

3 (4.5)

8 (12.1)

6 (8.5)

6 (8.5)

Strongly Disagree
Descriptive Norm: Most
people like me use a medicine
take-back box.
Strongly Agree
Agree

Perceived Behavioral Control:
I am confident that I could use
a medicine take-back box.
Strongly Agree
Agree
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Pre- and Post -Test Analysis
Behavior
Most respondents reported that they had not used a prescription drug take-back box within the
last month both pre- and post- survey collections. There were more people in Lowndes County at
the post-test survey who reported previous use of a prescription drug take-back box than any
other group. Because Lowndes was a control county, the increase in use during the post-survey
cannot be contributed to the PROMISE Mail Intervention.
Behavioral Intention
Respondents were unlikely to use a prescription drug take-back box within the next month. In
accordance with the Reasoned Action Approach, little to no intent of using the take-back boxes
will more than likely contribute to low use rates of prescription take back boxes.
Attitude
Respondents either viewed using a take-back box as “good” or “neither good nor bad”. Attitudes
of prescription take-back use remained the similar across control and intervention counties.
There were few individuals who viewed using a prescription take-back box as bad.
Injunctive Norms
Respondents equally agreed or were indifferent about whether people who were important to
them would approve of them using a medicine take-back box to dispose of their unused
medications. At the pre- and post- survey period, one respondent wrote “both of my sons are
pharmacists” under the space of this question.
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Descriptive Norms
Across the control and intervention counties, respondents neither agree nor disagree on people
who are like them use medicine take-back box to dispose of their unused medication.
Perceived Behavioral Control
Respondents agreed they were confident they could use a medicine take-back box. In the control
counites, there were slightly more responses indicating individuals “agree” they were confident
in using a take-back box. Among the intervention counties, there was little to no change among
responses related to confidence.

Multivariable Analysis
Mann Whitney U Test
There were no statistically significant results with behavioral intention (U= 1995.5, p=.101),
attitude (U=2188.5, p =.510), injunctive norms (U= 2308, p=.855), descriptive norms
(U=2036.5, p=.306), or perceived behavioral control (U=2164, p=.485).
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CHAPTER V
DISCUSSION
The PROMISE Mailer intervention did not have a significant impact on increasing the
use of prescription-drug take back boxes. Despite participants’ confidence in the ability to use a
prescription take-back box; there were little to no changes observed in the likelihood of them
using boxes as a method of disposal after receiving the intervention.
Several respondents left written comments on the survey to clarify their responses such
as: “Have no pain meds-ibuprofen”, “None (medicine take-back box) available”, “Meds don’t
require take-back box”, and “Dropbox is a hassle to get to”. Many of the comments were
duplicated among respondents. The comments provided by the respondents echoed sentiments
expressed by participants in other documented disposal campaigns; many of whom are unaware
of prescription drug take-back boxes (if there are any), do not view take-back boxes as the most
convenient method for disposal, as well as the belief that their medications do not qualify for this
form of disposal promoted in the campaign (i.e., Ibuprofen).
The findings from the PROMISE Mailed Intervention are similar to current literature in
which there were few people who disposed of their unused medication. There is a recurring
theme of prescription take-back boxes being inconvenient. The PROMISE Intervention differed
from the current literature because of the focus on prescription take-back boxes instead of
community take-back events like presented in previous studies. At the time of launching the
project, the team did not locate any literature of health promotion campaigns addressing
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prescription opioids in Mississippi. Therefore, the findings will contribute to the available
literature regarding the state, even with the null findings.
Unfortunately, the survey response rates and reported take-back box use was not ideal. At
the beginning of implementation, a few participants called the PROMISE office with skepticism
about the field experiment seeking to clarify they were not prescribed opioids or were not
misusing any prescribed medication. The undertones of these calls were that they feared were
inappropriately being targeted with this campaign because of prescription opioid use or misuse.
Considering the level of concern received from these callers, there is belief this could have been
a larger sentiment among survey recipients, thus, impacting the number of returned surveys. In
addition to the feedback from participants, there was also reflection on the timing in which the
mailers were dispersed. Implementation began during an election season. Because there may
have been an overwhelmingly amount of incoming mail, there is a chance the surveys were lost
in the heaps of mail. Future studies may need to consider a mail intervention during a season
where there are less anticipated mailed communications with the intended audience or adopt
another implementation format.
Strengths
Currently, there is limited information and literature available regarding prescription
opioid misuse and disposal interventions, especially in the state of Mississippi. The PROMISE
Initiative mail intervention provided an opportunity to gather the thoughts of rural Mississippians
as it relates to prescription opioid misuse and proper disposal methods. PROMISE also
contributed literature pertaining to prescription drug take-back boxes as a means for disposing
unused prescription opioid medications which has not yet been the primary method promoted in
disposal campaigns.
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Limitations
During the dissemination of the mail surveys, there were participants who did not
complete both the pre-test and post-test surveys (n=632), which inhibits the ability to accurately
measure any changes in behavioral intent before and after receiving the intervention among those
respondents. A potential downside of using the chosen mailing list is the instance that
respondents no longer lived in the county listed for them, which could have further weakened the
effect of the intervention because they received an address for a take-back box that is not
accurate.
Additionally, our sample was primarily made up of non-Hispanic White individuals who
were 60 years old or over. Neither the self-reported demographics of the respondents nor the
provided demographics on the Agricultural Communications mailing list were particularly
representative of the state, though they were largely representative of the Northeast part of the
state, which is considered Appalachian- a hotspot for the opioid epidemic. Lastly, this
intervention was only implemented in six out of the eighty-two counties in the state and may not
be generalizable to other counties.
Health Promotion Competencies
Mississippi State University’s Master of Science in Food Science, Nutrition, and Health
Promotion (Health Promotion concentration) and the Certified Health Education Specialist
professional certification prepares students to properly assess, design, implement, and evaluate
health promotion programs for an array of audiences. The PROMISE Initiative Mail Intervention
provided a hands-on experience with exercising these competencies. Prior to the design of the
prescription drug take-back box intervention, PROMISE team members reviewed available
research on the opioid epidemic and hosted community engagement forums to identify
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community members’ perceptions of the epidemic. The forums informed researchers there were
individuals who were unaware of prescription drug take-back boxes and their location followed
by concerns for medications being stolen from their homes (Robertson et al., 2019). These
conclusions led to the design of the mail intervention. During Fall 2019, implementation began
and ceased on-time in both the control and intervention counties. Quantitative and qualitative
data collection and analysis began as surveys were returned to the home office. After analyses
determined the PROMISE Mail Intervention did not have a significant impact on behavioral
intent, attitudes, or perceived behavior control – our team continued to educate the public of
other alternatives and convenient methods for proper medication disposal.
Implications for Future Research and Practice
Although the mailed intervention did not show a significant impact for increasing the
number of people using prescription drug take-back boxes, there were a few implications for
future research identified. One of those is the potential indication that mailer surveys may not be
an effective delivery method for this audience. This assumption is based on response rates and
comments collected from respondents. There were several participants who believed the postsurvey was a duplicate copy of the pre-survey and returned the mail unanswered. Perhaps,
providing more clear language in the mailed communications to participants could alleviate the
misconception.
Lack of awareness and inconvenience remain common responses among individuals who
are not currently using prescription take-back boxes or plan to use them in the future. These
responses persist despite the number of existing health promotion campaigns stating the
importance of safe and proper disposal of opioids. In the future, researchers may consider
continuing to promote proper, prescription opioid disposal through by presenting more
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convenient disposal methods, such as, DisposeRx, a powder that dissolves medications and allow
for safe disposal. In addition to promoting more convenient methods, future campaigns should
consider the lack of incentive present for individuals to dispose of their unused medications.
Keeping unused medication allows people to have additional medication for future use, this is
especially true if there are available refills on said medications. Beyond the potential for
diversion of medications by family members, there is also the potential for the illegal sale of
these medications as a source of income. This is an honest threat in communities with limited
opportunities and economic devastation as described earlier. In the future, campaigns could seek
to include more incentives for people to dispose of the unused medication beyond what is
already being promoted. To date, the opioid epidemic continues to be a public health crisis
across communities. It is recommended for future researchers to assess the unique, education
needs and preferences of their communities for optimal design of future interventions to further
promote proper and safe prescription drug disposal to combat opioid misuse.
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